J&J Reaches $2.1 Billion Deal to Sell Diabetes Device Business

(Bloomberg) -- Johnson & Johnson got a $2.1 billion offer from a private-equity firm for its glucose monitor business LifeScan, the drugmaker said Friday.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.